Ovariectomy aggravates nifedipine-induced flushing of tail skin in mice

European Journal of Pharmacology

Volumn 481, Issue 1, 2003, Pages 79-82

  Kai, Mamiko ^a   Tominaga, Koji ^a   Okimoto, Kisaragi ^a   Yamauchi, Atsushi ^a   Kai, Hisashi ^b   Kataoka, Yasufumi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Ca2+ channel antagonist; Flushing; Menopause; Nifedipine; Ovariectomy; Tail skin temperature

Indexed keywords

ESTRADIOL VALERATE; NIFEDIPINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ESTROGEN THERAPY; FEMALE; FLUSHING; MENOPAUSE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RISK FACTOR; SKIN; SKIN TEMPERATURE; TAIL;

EID: 0345016417     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.08.085     Document Type: Article

References (13)

1. Austin C.E. Chronic and acute effects of oestrogens on vascular contractility. J. Hypertens. 18:2000;1365-1378.
2. Dennerstein L. Well-being, symptoms and the menopausal transition. Maturitas. 23:1996;147-157.
3. Dougall H.T., McLay J. A comparative review of the adverse effects of calcium antagonists. Drug Safety. 15:1996;91-106.
4. Freedman R.R. Physiology of hot flashes. Am. J. Human Biol. 13:2001;453-464.
5. Kim Y.S., Park H.S., Sunwoo S., Byeon J.J., Song Y.M., Seo H.G., Kim C.H., Cheon K.S., Yoo S.M., Lee J.K. Short-term safety and tolerability of antihypertensive agents in Korean patients: an observational study. Pharmacoepidemiol. Drug Saf. 9:2000;603-609.
6. Kleinbloesem C.H., von Brummelen P., Donhof M., Faber H., Urquhart J., Breimer D.D. Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin. Pharmacol. Ther. 41:1987;26-30.
7. Kobayashi T., Tamura M., Hayashi M., Katsuura Y., Tanabe H., Ohta T., Komoriya K. Elevation of tail skin temperature in ovariectomized rats in relation to menopausal hot flushes. Am. J. Physiol., Regul. Integr. Comp. Physiol. 278:2000;R863-R869.
8. Kubota K., Pearce G.L., Inman W.H.W. Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoring. Eur. J. Clin. Pharmacol. 48:1995;1-7.
9. Morley J.E. Safety and efficacy of nifedipine 20 mg tablets in hypertension using electronic data collection in general practice. J. R. Soc. Med. 82:1989;272-275.
10. Stearns V., Ullmer L., Lopez J.F., Smith Y., Isaacs C., Hayes D.F. Hot flushes. Lancet. 360:2002;1851-1861.
11. Tominaga K., Kataoka Y., Sendo T., Furuta W., Niizeki M., Oishi R. Contrast medium-induced pulmonary vascular hyperpermeability is aggravated in a rat climacterium model. Invest. Radiol. 36:2001;131-135.
12. Tominaga K., Yamauchi A., Shuto H., Niizeki M., Makino K., Oishi R., Kataoka Y. Ovariectomy aggravates convulsions and hippocampal γ-aminobutyric acid inhibition induced by cyclosporine A in rats. Eur. J. Pharmacol. 430:2001;243-249.
13. Tominaga K., Kai M., Yamauchi A., Dohgu S., Toda K., Oishi R., Kataoka Y. Subchronic treatment with cyclosporine A decreases the binding properties of GABAA receptor in ovariectomized rats. Life Sci. 72:2002;75-80.